Nurse Practitioner, Family · Davenport, IA
NPI
1548249352
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1236 E Rusholme St, Suite 300
Davenport, IA, 52803
Phone (563) 324-2992
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
569 services
Medicare patients, 2024
454
Average age 74
Drug cost, 2024
$2.0M
5,566 prescriptions
Company payments, 2025
$141
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Judith A Deckert was code 99214 (office e&m - established), 393 times for 332 patients. In total Judith A Deckert billed 569 services in 15 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 393 | 332 | $68.50 | $27K |
| 99213 Office E&M - Established | Office | 101 | 101 | $44.19 | $4,464 |
| 99215 Office E&M - Established | Office | 32 | 32 | $102.08 | $3,266 |
| 99205 Office E&M - New | Office | 16 | 16 | $116.80 | $1,869 |
By year: 2022 $29K for 490 services; 2023 $43K for 587 services; 2024 $38K for 569 services.
Medicare prescription drug claims, 2024
In 2024, the drug Judith A Deckert prescribed most often to Medicare patients was Repatha Sureclick (Evolocumab), with 1,777 prescriptions and refills. In total Judith A Deckert wrote 5,566 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Repatha Sureclick Evolocumab | 1,777 | 2,249 | 255 | $1.3M |
| Ezetimibe Generic | 1,219 | 3,129 | 334 | $27K |
| Atorvastatin Calcium Generic | 611 | 1,689 | 173 | $5,332 |
| Praluent Pen Alirocumab | 560 | 730 | 91 | $369K |
| Rosuvastatin Calcium Generic | 480 | 1,287 | 152 | $5,965 |
| Vascepa Icosapent Ethyl | 141 | 253 | 27 | $88K |
| Fenofibrate Generic | 117 | 275 | 26 | $1,830 |
| Icosapent Ethyl Generic | 75 | 115 | 18 | $24K |
| Nexlizet Bempedoic Acid/Ezetimibe | 74 | 122 | 20 | $49K |
| Livalo Pitavastatin Calcium | 64 | 78 | Under 11 | $25K |
| Nexletol Bempedoic Acid | 62 | 96 | 11 | $38K |
| Repatha Pushtronex Evolocumab | 43 | 55 | Under 11 | $32K |
| Lovastatin Generic | 39 | 76 | Under 11 | $169 |
| Pravastatin Sodium Generic | 39 | 97 | 13 | $735 |
| Simvastatin Generic | 36 | 82 | Under 11 | $223 |
Brand drugs: 2,770 claims; generic drugs: 2,796 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Judith A Deckert $141 ($141 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $124.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.